Dresden, Germany

Anne-Karin Kahlert

This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Karin Kahlert. Retrieved from https://idiyas.com/inventor/anne-karin-kahlert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiology: The Contributions of Anne-Karin Kahlert

Introduction

Anne-Karin Kahlert is a notable inventor based in Dresden, Germany. She has made significant contributions to the field of cardiology, particularly in the treatment of heart conditions. Her work focuses on innovative methods that aim to improve patient outcomes in cardiovascular health.

Latest Patents

Kahlert holds a patent for the treatment of left ventricular non-compaction and dilated cardiomyopathy by inhibiting melanocortin receptor four. This patent outlines methods and compositions designed to address these serious heart conditions, showcasing her commitment to advancing medical science.

Career Highlights

Kahlert is affiliated with Brigham and Women's Hospital, Inc., where she collaborates with leading experts in the field. Her research and innovations have positioned her as a key figure in cardiology, contributing to the understanding and treatment of complex heart diseases.

Collaborations

One of her notable collaborators is Calum A Macrae, with whom she has worked on various projects aimed at enhancing cardiovascular treatments. Their partnership exemplifies the collaborative spirit that drives innovation in medical research.

Conclusion

Anne-Karin Kahlert's contributions to cardiology through her innovative patent and collaborative efforts highlight the importance of research in improving heart health. Her work continues to inspire advancements in the treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…